March 6th 2025
The FDA set the Prescription Drug User Fee Act (PDUFA) date for December 16, 2025.
Recognizing tracheobronchomalacia
August 1st 2006Abstract: Tracheobronchomalacia is a form of expiratory central airway collapse characterized by softening of the airway wall cartilaginous structures. Symptoms often mimic asthma and chronic obstructive pulmonary disease. Pulmonary function test results may suggest a diagnosis, but findings are neither sensitive nor specific. Bronchoscopy and novel dynamic radiographic studies contribute to the diagnosis and help differentiate true malacia from other forms of expiratory central airway collapse. Treatment options include medication; noninvasive ventilatory support; interventional bronchoscopy with airway stent insertion; and open surgical procedures, such as tracheostomy, tracheal resection, and tracheoplasty. (J Respir Dis. 2006;27(8):327-335)
Case In Point: A boy with shortness of breath, cough, and myalgias
August 1st 2006An 8-year-old boy presented with a 6-week history of shortness of breath, cough, and myalgias, but no fever. His pediatrician had made the diagnosis of bronchiolitis, and the patient was treated with azithromycin and albuterol via a metered-dose inhaler. Because the patient did not improve, he was given a 10-day course of amoxicillin, followed by a course of clarithromycin after a chest radiograph revealed bilateral infiltrates, suggesting atypical pneumonia.
Clinical Citations: Evaluating the reliability of the Asthma Control Test
August 1st 2006Effective asthma control involves the assessment of symptoms, changes in pulmonary function, and effects on quality of life and functional ability. A 5-item, patient-administered survey, the Asthma Control Test (ACT), has been developed as an assessment tool (Table). Investigators evaluated the reliability and validity of the ACT in a longitudinal study of patients with asthma who were new to the care of an asthma specialist.
Rapid Improvement in Lung Function After Asthmatics Quit Smoking
July 19th 2006GLASGOW, Scotland -- Within six weeks of their last cigarette, patients with asthma showed a "clinically significant" 15.2% improvement in lung function, a stark demonstration of the reversible component of the effects of smoking on the airways.
Assessment of Daytime Sleepiness: A Practical Approach
July 1st 2006Abstract: Although excessive daytime sleepiness is most often simply the result of inadequate sleep, other causes must be considered as well. Common causes of daytime sleepiness include obstructive sleep apnea/hypopnea syndrome (OSAHS) and medication side effects. The differential diagnosis also includes narcolepsy and restless legs syndrome (RLS). In many cases, the answers to a few simple questions can provide the necessary clues to the diagnosis. Loud snoring is associated with OSAHS, while sudden muscle weakness triggered by intense emotion is consistent with narcolepsy. Referral for sleep evaluation is indicated to evaluate for OSAHS, narcolepsy, RLS, and idiopathic hypersomnia. Methods of measuring daytime sleepiness include the Multiple Sleep Latency Test and the Epworth Sleepiness Scale. (J Respir Dis. 2005;26(6):253-259)
Aspirin-exacerbated respiratory disease: An easy-to-overlook diagnosis
July 1st 2006Abstract: Patients who have aspirin-exacerbated respiratory disease (AERD) usually experience upper and lower respiratory tract symptoms about 1Z|x to 2 hours after taking aspirin or another NSAID that inhibits the enzyme cyclooxygenase-1. In addition to symptoms such as nasal congestion, rhinorrhea, paroxysmal sneezing, periorbital edema, laryngospasm, and intense flushing, patients may have severe--often life-threatening--exacerbations of asthma. AERD occurs in about 10% to 20% of patients with asthma and in about 30% of asthmatic patients with nasal polyposis. However, AERD also occurs in patients who do not have any of these predispos- ing conditions. In patients with AERD, aspirin desensitization can improve asthma control, reduce the need for corticosteroids, and reduce the need for sinus surgery. (J Respir Dis. 2006;27(7):282-290)
Quick Take: When to consider allergy referral, part 1: Asthma
July 1st 2006The American Academy of Allergy, Asthma, and Immunology (AAAAI) recently published guidelines for referring patients to an allergist/immunologist.1 The recommendations address topics such as rhinitis, asthma, cough, anaphylaxis, dermatitis, urticaria, and food allergy.
U.S. Surgeon General Embraces Workplace Smoking Ban
June 27th 2006WASHINGTON - Calling secondhand tobacco smoke a significant risk to cardiovascular health, the U.S. Surgeon General today praised states and municipalities that have a banned smoking in the workplace, in bars, and in other public places.
Post-Marketing Trials Viewed as Marketing Ploy
June 21st 2006ODENSE, Denmark ? When individual physicians take part in a drug trial, their developing familiarity with a drug they are testing makes them more likely to use it in everyday practice, suggesting that post-marketing clinical trials are an effective sales tool.
How best to diagnose and control asthma in the elderly
June 1st 2006Abstract: A number of factors can complicate the diagnosis of asthma in elderly patients. For example, the elderly are more likely to have diseases such as chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) that--like asthma--can cause cough, dyspnea, and wheezing. Spirometry can help distinguish asthma from COPD, and chest radiography and measurement of brain natriuretic peptide levels can help identify CHF. Important considerations in the management of asthma include drug side effects, drug interactions, and difficulty in using metered-dose inhalers. When discussing the goals of therapy with the patient, remember that quality-of-life issues, such as the ability to live independently and to participate in leisure activities, can be stronger motivators than objective measures of pulmonary function. (J Respir Dis. 2006;27(6):238-247)
Clinical Consultation: Nebulizers as a source of allergens
May 1st 2006Recent reports have identified potentialrisks of nebulizer use in patientswith environmental allergies.1,2 One report described 2 childrenwith asthma and cockroachallergy who had life-threateningworsening of asthma after using anebulizer to treat an exacerbation.1